Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Coperion
Coperion
Activities:
Manufacturing
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Coperion offers new pharma extruder design with maximum flexibility
The ZSK 18 MEGAlab extruder offers higher efficiency and uniformity than batch processes
Manufacturing
Sixty years of ZSK twin screw extruders
The ZSK twin screw extruder, the ‘forefather’ of all twin screw extruders, celebrates its 60th anniversary this year
Manufacturing
Coperion K-Tron announces new pharmaceutical feeder design
A highly accurate feeding solution for growing demands of continuous processing, which will be displayed at Powtech 2017
Manufacturing
Coperion has a new President and Chairman of the executive board
Board member Thomas Kehl takes up the role
Design and Implementation of Continuous Pharmaceutical Manufacturing Processes
<b>12 - 14 December 2012</b><br> <i>Three-day course</i><br> Zurich, Switzerland
Design and Implementation of Continuous Pharmaceutical Manufacturing Processes
<b>28 - 30 November 2012</b><br> <i>Three-day course</i><br> Bethesda, MD, US
Manufacturing
Hillenbrand agrees purchase of Coperion
The €408m deal is expected to close by 31 December
Subscribe now